Browsing Pathways
Showing 661 -
670 of 605359 pathways
SMPDB ID | Pathway Name and Description | Pathway Class | Chemical Compounds | Proteins |
---|---|---|---|---|
SMP0130404View Pathway |
Tisotumab vedotin Drug Metabolism |
|
||
SMP0129626View Pathway |
Tislelizumab Drug Metabolism |
|
||
SMP0129173View Pathway |
Tisagenlecleucel Drug Metabolism |
|
||
SMP0129714View Pathway |
Tirzepatide Drug Metabolism |
|
||
SMP0143216View Pathway |
Tirofiban Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0126470View Pathway |
Tirofiban Action Pathway (new)Tirofiban is a platelet aggregation inhibitor, also known under the brand name Aggrastat, it is used to prevent thrombotic events from occurring in those who are high-risk. It is administered intravenously and acts as an antagonist of the platelet glycoprotein IIb/IIIa receptor, this receptor is responsible for platelet aggregation in order to form a thrombus, without this signal from the receptor it stops aggregation. This inhibition created by the drug will cease once the drug is no longer infused into the patient's bloodstream.
|
Drug Action
|
||
SMP0000267View Pathway |
Tirofiban Action PathwayTirofiban is a platelet aggregation inhibitor drug sold under the name Aggrastat. It is specifically a small molecule that inhibits the glycoprotein IIb/IIIa receptor of platelets. It is administered intravenously, and can act to decrease platelet aggregation by over 90% after the infusion, and can help prevent aggregation for up to two days after administration. In the vein, tirofiban causes a conformational change in the integrins on the surface of activated platelets. This prevents the binding of fibrinogen to these integrins, which in turn prevents the platelets from being held together by these fibrinogen fibres. The conformational change also prevents the binding of von Willebrand factor to the platelets, which also prevents aggregation and adhesion.
|
Drug Action
|
||
SMP0143988View Pathway |
Tirbanibulin Drug Metabolism Action Pathway |
Drug Action
|
|
|
SMP0130208View Pathway |
Tiragolumab Drug Metabolism |
|
||
SMP0143364View Pathway |
Tipranavir Drug Metabolism Action Pathway |
Drug Action
|
|
Showing 661 -
670 of 65005 pathways